Inventprise is a biotechnology company specializing in GMP vaccine product development.
Inventprise has raised $3.5M in total funding. The most recent round was Debt Financing. The last funding was announced in November 2021.
Inventprise's investors include Bill & Melinda Gates Foundation.
Inventprise is headquartered in Redmond, United States.
Inventprise is a biotechnology company specializing in GMP vaccine product development.
Inventprise is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inventprise — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/inventprise. Accessed August 14, 2026.
VCBacked. (2021). Inventprise — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/inventprise
{{cite web |title=Inventprise — Funding & Investors |url=https://www.vcbacked.co/company/inventprise |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated